Literature DB >> 9521838

The association of tau-like proteins with vimentin filaments in cultured cells.

C Capote1, R B Maccioni.   

Abstract

There is increasing evidence that the different polymers that constitute the cytoskeleton are interconnected to form a three-dimensional network. The macromolecular interaction patterns that stabilize this network and its intrinsic dynamics are the basis for numerous cellular processes. Within this context, in vitro studies have pointed to the existence of specific associations between microtubules, microfilaments, and intermediate filaments. It has also been postulated that microtubule-associated proteins (MAPs) are directly involved in mediating these interactions. The interactions of tau with vimentin filaments, and its relationships with other filaments of the cytoskeletal network, were analyzed in SW-13 adenocarcinoma cells, through an integrated approach that included biochemical and immunological studies. This cell line has the advantage of presenting a wild-type clone (vim+) and a mutant clone (vim-) which is deficient in vimentin expression. We analyzed the cellular roles of tau, focusing on its interactions with vimentin filaments, within the context of its functional aspects in the organization of the cytoskeletal network. Cosedimentation experiments of microtubular protein with vimentin in cell extracts enriched in intermediate filaments, combined with studies on the direct interaction of tau with nitrocellulose-bound vimentin and analysis of tau binding to vimentin immobilized in single-strand DNA affinity columns, indicate that tau interacts with the vimentin network. These studies were confirmed by a quantitative analysis of the immunofluorescence patterns of cytoskeleton-associated tubulin, tau, and vimentin using flow cytometry. In this regard, a decrease in the levels of tau associated to the cytoskeletal network in the vim- cell mutant compared with the wild-type clones was observed. However, immunofluorescence data on SW-13 cells suggest that the absence of a structured network of vimentin in the mutant vim- cells does not affect the cytoplasmic organization formed by microtubules and actin filaments, when compared with the wild-type vim+ cells. These studies suggest that tau associates with vimentin filaments and that these interactions may play a structural role in cells containing these filaments.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521838     DOI: 10.1006/excr.1997.3902

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  5 in total

1.  Differential association of tau with subsets of microtubules containing posttranslationally-modified tubulin variants in neuroblastoma cells.

Authors:  L Saragoni; P Hernández; R B Maccioni
Journal:  Neurochem Res       Date:  2000-01       Impact factor: 3.996

2.  A quantitative assay for mitochondrial fusion using Renilla luciferase complementation.

Authors:  Huiyan Huang; Seok-Yong Choi; Michael A Frohman
Journal:  Mitochondrion       Date:  2010-05-19       Impact factor: 4.160

3.  DHA-mediated regulation of lung cancer cell migration is not directly associated with Gelsolin or Vimentin expression.

Authors:  Mehboob Ali; Kathryn Heyob; Lynette K Rogers
Journal:  Life Sci       Date:  2016-05-05       Impact factor: 5.037

4.  Reprogramming of tau alternative splicing by spliceosome-mediated RNA trans-splicing: implications for tauopathies.

Authors:  Teresa Rodriguez-Martin; Mariano A Garcia-Blanco; S Gary Mansfield; Andrew C Grover; Michael Hutton; Qingming Yu; Jianhua Zhou; Brian H Anderton; Jean-Marc Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

5.  Diverse homeostatic and immunomodulatory roles of immune cells in the developing mouse lung at single cell resolution.

Authors:  Racquel Domingo-Gonzalez; Fabio Zanini; Stephen R Quake; David N Cornfield; Cristina M Alvira; Xibing Che; Min Liu; Robert C Jones; Michael A Swift
Journal:  Elife       Date:  2020-06-02       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.